Onex Canada Asset Management Inc. Purchases 130,676 Shares of Sotera Health Company $SHC

Onex Canada Asset Management Inc. raised its position in shares of Sotera Health Company (NASDAQ:SHC) by 31.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 544,771 shares of the company’s stock after acquiring an additional 130,676 shares during the quarter. Sotera Health comprises 1.1% of Onex Canada Asset Management Inc.’s investment portfolio, making the stock its 27th biggest holding. Onex Canada Asset Management Inc. owned about 0.19% of Sotera Health worth $8,569,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Broyhill Asset Management LLC bought a new position in Sotera Health during the third quarter worth $455,000. Vise Technologies Inc. grew its holdings in Sotera Health by 18.4% in the third quarter. Vise Technologies Inc. now owns 15,785 shares of the company’s stock worth $248,000 after purchasing an additional 2,448 shares during the period. Invesco Ltd. increased its stake in Sotera Health by 5.8% in the third quarter. Invesco Ltd. now owns 337,626 shares of the company’s stock valued at $5,311,000 after purchasing an additional 18,470 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Sotera Health by 426.3% during the third quarter. BNP Paribas Financial Markets now owns 76,489 shares of the company’s stock valued at $1,203,000 after purchasing an additional 61,955 shares during the period. Finally, Magnetar Financial LLC acquired a new position in shares of Sotera Health during the third quarter valued at about $304,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the transaction, the director directly owned 12,735,301 shares of the company’s stock, valued at $194,468,046.27. This trade represents a 43.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 47.55% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Piper Sandler upgraded Sotera Health from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $17.00 to $24.00 in a report on Friday, January 9th. Citigroup boosted their price objective on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Wells Fargo & Company lowered Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. William Blair assumed coverage on Sotera Health in a report on Thursday, December 18th. They issued an “outperform” rating on the stock. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and an average target price of $20.43.

Sotera Health Trading Up 0.7%

Shares of SHC stock opened at $13.41 on Friday. The company has a 50 day moving average of $17.35 and a 200-day moving average of $16.75. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66. Sotera Health Company has a 12-month low of $9.53 and a 12-month high of $19.85. The firm has a market cap of $3.81 billion, a P/E ratio of 49.67 and a beta of 1.84.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The firm had revenue of $303.44 million for the quarter, compared to analysts’ expectations of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Sell-side analysts anticipate that Sotera Health Company will post 0.61 earnings per share for the current year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.